Regulation of TNF-alpha, IL-1 and IL-6 synthesis in differentiating human monoblastoid leukemic U937 cells.

[1]  F. Cozzolino,et al.  A novel secretory pathway for interleukin‐1 beta, a protein lacking a signal sequence. , 1990, The EMBO journal.

[2]  T. Hirano,et al.  Mechanisms of differential regulation of interleukin‐6 mRNA accumulation by tumor necrosis factor alpha and lymphotoxin during monocytic differentiation , 1990, FEBS letters.

[3]  A. Hartmann,et al.  Differentiation and retrodifferentiation of U937 cells: reversible induction and suppression of intermediate filament protein synthesis. , 1990, European journal of cell biology.

[4]  K. Resch,et al.  Alterations in glycosylation and lectin pattern during phorbol ester-induced differentiation of U937 cells. , 1990, Cancer research.

[5]  W. Vainchenker,et al.  Regulation of the expression of IL-6 in human monocytes. , 1989, Journal of immunology.

[6]  K. Resch,et al.  TPA-induced differentiation and adhesion of U937 cells: changes in ultrastructure, cytoskeletal organization and expression of cell surface antigens. , 1989, European journal of cell biology.

[7]  J. K. Pullen,et al.  Regulation of IL-1 and TNF-alpha expression during the differentiation of bone marrow derived macrophage. , 1989, Journal of immunology.

[8]  T. Nishida,et al.  The transcription of the interleukin 1 beta gene is induced with PMA and inhibited with dexamethasone in U937 cells. , 1988, Biochemical and biophysical research communications.

[9]  C. Dinarello,et al.  Production of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage colony-stimulating factor. , 1988, Blood.

[10]  D. Hazuda,et al.  The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. , 1988, The Journal of biological chemistry.

[11]  K. Resch,et al.  Interleukin 1: more than a mediator between leukocytes. , 1988, Trends in pharmacological sciences.

[12]  D. Kufe,et al.  Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. , 1988, The Journal of clinical investigation.

[13]  P. Scheurich,et al.  Tumor necrosis factor-induced changes of gene expression in U937 cells. Differentiation-dependent plasticity of the responsive state. , 1988, Journal of immunology.

[14]  J. Harris,et al.  Labelling of lipids and phospholipids with [3H]arachidonic acid and the biosynthesis of eicosanoids in U937 cells differentiated by phorbol ester. , 1988, Biochimica et biophysica acta.

[15]  J. Meer,et al.  Concentrations of Immunoreactive Human Tumor Necrosis Factor Alpha Produced by Human Mononuclear Cells In Vitro , 1988, Journal of leukocyte biology.

[16]  A. Tsou,et al.  Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[17]  T. Strom,et al.  Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. , 1987, Journal of immunology.

[18]  H. Holtmann,et al.  Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate. , 1987, Journal of immunology.

[19]  R. Rothlein,et al.  Membrane-associated interleukin 1 activity on human U937 tumor cells: stimulation of PGE2 production by human chondrosarcoma cells. , 1987, Journal of immunology.

[20]  T. Strom,et al.  Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. , 1986, Journal of immunology.

[21]  B. Beutler,et al.  Effect of gamma interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype , 1986, The Journal of experimental medicine.

[22]  R. Philip,et al.  Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1 , 1986, Nature.

[23]  J. Vilček,et al.  Characterization and affinity crosslinking of receptors for tumor necrosis factor on human cells. , 1986, Archives of biochemistry and biophysics.

[24]  E. Unanue,et al.  In vivo and in vitro expression of macrophage membrane interleukin 1 in response to soluble and particulate stimuli. , 1986, Journal of immunology.

[25]  B. Beutler,et al.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1 , 1986, The Journal of experimental medicine.

[26]  J. Larrick,et al.  Regulation of macrophage tumor necrosis factor production by prostaglandin E2. , 1986, Biochemical and biophysical research communications.

[27]  B. Beutler,et al.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. , 1986, Science.

[28]  T. Strom,et al.  Purification and characterization of a unique human interleukin 1 from the tumor cell line U937. , 1986, Journal of immunology.

[29]  S. Kunkel,et al.  Prostaglandins as endogenous mediators of interleukin 1 production. , 1986, Journal of immunology.

[30]  D. Goeddel,et al.  Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta. , 1985, Journal of immunology.

[31]  M. Redinbaugh,et al.  Adaptation of the dye-binding protein assay to microtiter plates. , 1985, Analytical biochemistry.

[32]  W. Fiers,et al.  Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes. , 1985, Journal of immunology.

[33]  J. Oppenheim,et al.  Interleukin 1 activity in normal human urine. , 1984, Journal of immunology.

[34]  D. Wallach.  Preparations of lymphotoxin induce resistance to their own cytotoxic effect. , 1984, Journal of immunology.

[35]  M. Cohen,et al.  Vitamin D metabolites change the phenotype of monoblastic U937 cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[37]  E. Unanue,et al.  Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. , 1982, Journal of immunology.

[38]  I. Olsson,et al.  Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3':5'-monophosphate-inducing agents. , 1982, Cancer research.

[39]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[40]  S. Mizel,et al.  Characterization of lymphocyte-activating factor (LAF) produced by human mononuclear cells: biochemical relationship of high and low molecular weight forms of LAF. , 1979, Journal of immunology.

[41]  K. Nilsson,et al.  Establishment and characterization of a human histiocytic lymphoma cell line (U‐937) , 1976, International journal of cancer.

[42]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[43]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[44]  I. Gery,et al.  POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS , 1972, The Journal of experimental medicine.

[45]  I. Gery,et al.  POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS , 1972, The Journal of experimental medicine.

[46]  W. Crosby,et al.  Cytochemical identification of monocytes and granulocytes. , 1971, American journal of clinical pathology.

[47]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[48]  D. Nathan,et al.  Quantitative nitroblue tetrazolium test in chronic granulomatous disease. , 1968, The New England journal of medicine.

[49]  H. Flad,et al.  Interleukin 1 and tumor necrosis factor: studies on the induction by lipopolysaccharide partial structures. , 1989, Lymphokine research.

[50]  P. Nowell,et al.  Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. , 1988, The Journal of clinical investigation.

[51]  C. Dinarello,et al.  A radioimmunoassay for human interleukin-1 alpha: measurement of IL-1 alpha produced in vitro by human blood mononuclear cells stimulated with endotoxin. , 1988, Lymphokine research.

[52]  J. Meer,et al.  A radioimmunoassay for human interleukin-1a: measurement of IL-1a produced in vitro by human blood mononuclear cells stimulated with endotoxin , 1988 .

[53]  D. Männel,et al.  Autocrine stimulation of TNF-alpha mRNA expression in HL-60 cells. , 1987, Lymphokine research.

[54]  C. Dinarello,et al.  Development and use of a radioimmunoassay for human interleukin-1 beta. , 1987, Lymphokine research.

[55]  P. Ralph,et al.  Distinct activities of interferon-gamma, lymphokine and cytokine differentiation-inducing factors acting on the human monoblastic leukemia cell line U937. , 1985, Cancer research.